结直肠癌,循环肿瘤细胞,微波消融," /> 结直肠癌,循环肿瘤细胞,微波消融,"/> Colorectal cancer,Circulating tumor cell,Microwave ablation,"/>  <span style="font-family:宋体;">Monitoring of circulating tumor cells in patients with liver metastases from colorectal cancer undergoing microwave ablation</span>

Chinese Clinical Oncology ›› 2018, Vol. 23 ›› Issue (10): 925-930.

Previous Articles     Next Articles

 Monitoring of circulating tumor cells in patients with liver metastases from colorectal cancer undergoing microwave ablation

  

  1. Department of Oncology the Second Hospital of Nanjing Nanjing Hospital Affiliated to Nanjing University of Traditional Chinese Medicine Nanjing 210003
  • Received:2018-05-12 Revised:2018-08-20 Online:2018-10-31 Published:2019-03-20
  • Contact: XU Hanfeng E-mail: xuhanfeng1820@qq.com

Abstract:  

Objective  To investigate the clinical value of circulating tumor cells CTCs in evaluating the prognostic value in patients with metastatic colorectal cancer undergoing microwave ablation. Methods  A total of 29 patients who received microwave ablation for hepatic metastases from colorectal cancer at the Second Hospital of Nanjing from January 2014 to May 2018 were enrolled in this study. Preoperative and postoperative blood samples from these patients were tested for CTCs. CTCs values and clinical data of the 29 cases were analyed. The data was analyzed by Chi square test or Fisher exact test, and the survival analysis was performed by Kaplan-Meier method and Log-rank test. Results  The short-term efficacy of microwave ablation for local lesions in 29 patients was assessed by imaging. The short-term outcome was complete ablation in 8 patients partial ablation in 16 patients and progressive ablation in 5 patients. An increase in CTCs values after microwave ablation was found Z=-2.489 P=0.013. While age sex synchronous colorectal liver metastasis or not left or right colorectal cancer and the change of CTC values after microwave ablation were no statistically significant P0.05. The shortterm effect of local liver metastases in patients with CTCs 7/ml after microwave ablation was better than that in patients with CTCs 7/ml, and the difference was statistically significant P=0.031. The median overall survivalOS of 29 patients was 30.0 months 95CI 10.7-49.3 months. The median OS of patients under 60 years old were better than those aged 60 and aboveP=0.008. The median OS in patients with left colon cancer was better than that in patients with right colon cancerP=0.028. The patients with microwave ablation only have worse survival than combined treatmentP=0.001. But gender simultaneous or heterogeneous liver metastasis elevated CTCs and postoperative CTCsml were not associated with median OS P0.05. Conclusion  Microwave ablation is an effective method for local treatment of colorectal cancer with liver metastases. Monitoring the number of CTCs before and after treatment may be helpful to evaluate the shortterm curative effects.

Key words:  , Colorectal cancer">Colorectal cancer')">">, Circulating tumor cell, Microwave ablation

CLC Number: 

  • R735.3
[1] YUAN Jianhua, LI Jianwang, MAO Shanshan, CUI Ronghua, WANG Meiqing..  Expression and clinical significance of Livin in stage - colorectal cancer [J]. Chinese Clinical Oncology, 2018, 23(10): 910-914.
[2] WANG Xinwei, LV Ke, SONG Zhan, QIAN Guowu, YU Sijun..  ADAM15 promotes metastasis and invasion of colorectal cancer cells by activating EGFR [J]. Chinese Clinical Oncology, 2018, 23(10): 881-885.
[3] HE Zhijun, WU Lianbao, HAN Jiang. .  Effects of enhanced recovery after surgery in perioperative period of colorectal cancer [J]. Chinese Clinical Oncology, 2018, 23(10): 931-936.
[4] ZHANG Dezhi, ZHANG Yu, ZHU Shaogong.. Effect of rs10013228 polymorphism of VEGFR2 gene on prognosis of patients with R0 resection of colorectal cancer [J]. Chinese Clinical Oncology, 2018, 23(5): 424-428.
[5] YAO Bo, LU Na.. The role of radiotherapy in the management of rectal cancer with synchronous metastases [J]. Chinese Clinical Oncology, 2018, 23(5): 463-466.
[6] MENG Cunying, AN Tai, SHI Shengmei, ZHANG Chunli, LIU Yan, YUAN Donghong, MA Ying, LIU Pengfei.. Expression of DCLK1 and Bmi-1 in colorectal cancer and their clinical significance [J]. Chinese Clinical Oncology, 2018, 23(5): 419-423.
[7] WANG Shanshan, WANG Haiyan, WU Bin, ZHAO Lihong, LI Dong, XIE Yan. . Observation of apatinib mesylate treatment on colon cancer failed in multi-line chemotherapy [J]. Chinese Clinical Oncology, 2018, 23(5): 453-457.
[8] YANG Yefan, MA Zhonghua, WANG Keming.. Progression of long chain non coding RNA in the regulation of drug resistance in colorectal cancer [J]. Chinese Clinical Oncology, 2018, 23(5): 458-462.
[9] . Progression of monocolonal antibodies for colorectal cancer in 2008 [J]. Chinese Clinical Oncology, 2009, 14(1): 1-.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!